OGRA Foundation - Action Data Initiative

Congratulations! This Entry has been selected as a semifinalist.

OGRA Foundation - Action Data Initiative: Generating actionable data through reliable and enthusiastic health front liners

Kisumu, KenyaKisumu, Kenya
Year Founded:
2005
Organization type: 
nonprofit/ngo/citizen sector
Project Stage:
Idea
Budget: 
$10,000 - $50,000
Project Summary
Elevator Pitch

Concise Summary: Help us pitch this solution! Provide an explanation within 3-4 short sentences.

DATA is MERELY data UNTIL it is ACTIONABLE !! Enthusiastic Front liners are the only consistent & permanent base-partners in the health continuum. Action Data Initiative is developing ways to use mobile technology & diagnostic data to improve heath outcomes across this continuum via Front liners.

WHAT IF - Inspiration: Write one sentence that describes a way that your project dares to ask, "WHAT IF?"

What if health front-liners saw the common good of collecting and protecting data for the best health outcomes, and that they collected this data freely, accurately and promptly ?
About Project

Problem: What problem is this project trying to address?

Data is key in decision making. In Kenya for example, the health information system is digitized up to the district level, leaving data processing below the districts manual. Mostly this data is received 4-6 weeks after the event. Most raw data is collected incomplete, inaccurate and submitted late. Because of above, the project is envisioning coming up with a user friendly real-time actionable data system targeting remote low level facilities.

Solution: What is the proposed solution? Please be specific!

Action Data Initiative (ADI) aims at designing an electronic template, via a USSD on phones and application on tablets/PCs, that is in line with the Ministry of health, Kenya with reporting parameters that will be used by front-line health professional in both government and private health facilities. The designing will involve both Boehringer Ingelheim (BI), OGRA Foundation and the front line health personnel that are presently delivering healthcare to the communities in both remote mainland and the far away Island in the lake within our project area. These facilities are endowed with a 24 hour mains electricity supply, solar panels and one in the Island has a wind powered electricity source and are the best fit for our first phase work.

Awards

Non so far.
Impact: How does it Work

Example: Walk us through a specific example(s) of how this solution makes a difference; include its primary activities.

Tom, a health program manager and team of project officers, find it challenging to get data real-time whenever they ask for them. Time is wasted every time health staff have to get back to them,most often, with data/information that is preliminary. The data that comes later ( between 6 hours and two days on average) remains different , a disparity that affects decisions like 'topping up stocks of syringes'. If only the front line staff in the field could find a " one touch button" that could submit data and help the Head Office process their exact need in time, then a lot of time resources wasted could be a thing of the past and Field staff would no longer complain about challenges of data-related decisions at their level.

Impact: What is the impact of the work to date? Also describe the projected future impact for the coming years.

The use of electronic systems , though not standardized across all our sister service delivery points (SDPs), has proved to be superior to manual system. For example , we have a 96% complete, timely and appropriate data in two of our facilities out of the over 40 health facilities at the grassroots,whereas a below 40% in 7 new health facilities. Of importance is the fact that these facilities do not have a computers and are yet to be staffed with pro-tech staff. The project currently aims at improving health outcomes through prudent application of data processing and management best practices across all SDPs. Our project ( Operation Karibu ) , that was done in partnership with a local partner gives more credibility and evidence to this. In future , we see ourselves as the key generators and drivers of appropriate data use through Actioning Data Initiative (ADI) at the grassroots.

Spread Strategies: Moving forward, what are the main strategies for scaling impact?

The project 's presence in most terrains in west Kenya means that the use of data for measuring health outcome will be applicable in the Island, flood prone planes, mountainous areas and along the beaches that have rampant issues revolving around ill-health and poverty. By involving the local front line staff in the designs of the product, we believe that we shall achieve community participation and ownership . Finally, our corporate partners , the Boehringer Ingelheim will add value in terms of their expertise in innovation, fund raising and marketing. These will ensure sustainability.
Sustainability

Financial Sustainability Plan: What is this solution’s plan to ensure financial sustainability?

The aim is to demonstrate value for money and have a visible revenue stream though the use of user friendly cash collection system at the initial stage. Working with Boehringer Ingelheim and with our experiences in social entrepreneurship, we will use the best financial practices including market research and price/fees setting. We will use the successes to sell the model and product to both private and public health facilitate.

Marketplace: Who else is addressing the problem outlined here? How does the proposed project differ from these approaches?

Currently there is no one who is thinking like we do. Most approaches use silo or stand alone models. We will be for the first time approaching different situations and population at one go. Our front line staff will strive to collect real-time actionable data from populations in the Islands, the main land, along the beaches and the difficult mountainous terrains. It is about giving everyone an opportunity to improve their lives and health.
Team

Founding Story

OGRA Foundation was founded by Dr Hezron McOBewa and Mr Odida Charles. They have since moved to sit in the Board. for more information on OGRA Foundation, please visit www.ografoundation.org The proposed project, Actioning Data Initiative (ADI) is the brain-child of Kenneth Obiero, a social Intraprenuer.

Team

The current team consist of Kenneth Obiero, Health Program Manager. who has worked in OGRA Foundation for the past 10 years. Holds a masters degree in community health and developmet. Dr Hezron McObewa, Board Treasurer at OGRA Fundation. Medical doctor with MPH and Gabriel Amollo, CEO , OGRA Foundation The team will evolve to have a full time Project Manager with knowledge and experience in project management, a full time ICT computer programmer with recent engagegement in mobile application programming/develeopment, part time an accountant to manage the venture finances ( aleady working at OGRA Foundation), Health care workers( Nurses, Clinical Officers) with competencies and experience in healthcare deleivery at the community level ( part time ), full time Field Officers/ community health volunteers with competencies and experiences in community health (workers) and a full time driver
CO-CREATION IDEA: Please offer a brief description of how you imagine a win-win partnership with Boehringer Ingelheim to better serve unmet needs in health. (Hint: Please mention the underlying business model envisioned that would make such a partnership sustainable.)

OGRA Foundation and BI share in reaching out to populations that are in need of healthcare. Through this partnership , OGRA Foundation will scale up its venture as BI plays its corporate role. We envisage a win-win situation as we build a strong BusinessGood-PeopleGood model. We equally anticipate a work environment that is not only data driven but a front line staff who look beyond data; seeing data as evidence to both demonstrate success and to improve performance. The vision is to scout health care workers and teams who have a drive to create and use data for best health outcomes

NEEDS: Based on you response above, please specify which of the following resources, operations or expertise by Boehringer Ingelheim you imagine leveraging to actualize the proposed co-creation opportunity. Please check all that apply. (Hint: while financing is often critical to scale, we are also interested in understanding what other assets or expertise could be leveraged).

Distribution Channels, Marketing/Communications Support, Technology Expertise, Access to Capital.

EXPLANATION OF NEEDS: Please explain your choices in more detail.

Action Data Initiative (ADI) will be requesting for some level of funding from BI in order to come up with the design, development and field testing of the product. At the designing level, ADI will together with BI co-create with a prototype that will eventually need a technological expertise which we hope to get from BI. The products once designed and tested will need a ready market both locally and globally

OFFER: What are the main assets you may contribute in a co-creation partnership with Boehringer Ingelheim that would better serve unmet needs in health?

Deep understanding of an unmet need in a specific market/context, Access to and established trust with customers/beneficiaries, Insights into pricing and financing of health products/services, Insights into behavior change.

FOCUS AREAS: Which of the following best describes the main focus of your project? (select all that apply)

Holistic solutions that work across the entire care continuum (including education, prevention, detection, treatment, management, follow-up), Remote care solutions for health management, treatment, and diagnosis, Packaging of health products and services to address needs currently unmet.

SECONDARY ENTRY FORM
Please share what your organisation and Boehringer Ingelheim will Co-Create together

The Action Data Initiative will co-create innovations that make use of improved data collection, filtering , analysis and visualization leveraging existing and emerging technologies. The Venture aims to produce new value from data collection processes while encouraging real time or near-real time analysis and visualization. As a pilot, we will co-create a clinical trial tracking system for efficient, private and ethical collection of field data, saving time, resources and producing insights on trends.

Please specify what your Co-Creation will result in:

a new service, a new distribution channel, a new market/customer group.

If you selected "other" above, please explain:
Please provide a 1-2 sentence summary of your Co-Creation idea

Data is merely data until it is actionable ! The Action Data Initiative plans to design, develop and co-create systems for collecting, analyzing and visualizing diagnostics data for improved health outcomes. We envision empowering community health volunteers in collection of actionable data for analizing and visualization.

How does this project link to the core mission of your organisation?

The appropriate collection and analysis of data translates to advocacy for best health outcomes and aligns with OGRA Foundation's implementation strategy pillars. The Action Data Initiative will also create benefits for the community health volunteers through data skills transfer and training. The meaningful and actionable data generated will equally drive quick responses during disease outbreaks. Our department of Monitoring , Evaluation and research that looks into data, information and "answers" to community needs will gain through this project

Beyond social impact, how does this project link to Boehringer Ingelheim’s core business?

The Action Data Initiative could link to BI core business in the following ways;
1) Diagnosis data for patients- The more patients diagnosed, the better the ability to respond with medicines. This leads to more sales through BI-OGRA Foundation co-supply chain,
2) Stopping Counterfeit medicines- This is a huge emerging issue for all pharmaceutical companies, but on , BI is fighting head on. Being able to prove that this can work at the project level can make it possible to globalize that best practice/talent.
3) Diagnostic information-Fewer medications going to waste; ability to track medicines in rural areas can lead to fewer medicines going to waste.
4) Future- This initiative can be expanded possibly to clinical trials, making it easier to get participation
5) Most important- the patients' diagnostic data is treated ethically and thoughtfully for increasing quality of life and productivity.
This initiative will help BI co-create with a team of health professionals and project monitors who have been involved in supply of medicines to point of care before. We plan to avail, through our offices and in-country agents, the medicines from Boerhinger Ingelheim to both corporate and public clients who pay for cash or on medical insurance. Our endemic Burkitt's Lymhoma (eBL) project that targets children, that runs a sensitization, screening, testing, diagnosis, treatment and follow up, is a good platform to initiate clinical trials in oncology. Malaria and acute bacterial meningitis also form a good case for studies. eBL affects children and is associated with EBV virus and blood plasmodium infection.

What are the specific inputs and actions that each side will contribute to this Co-Creation idea based on each of your unique competencies and experiences?

My organization will contribute: OGRA Foundation- The Action Data Initiative
1. Providing expertise on health data delivery and diagnosis needs in the hard to reach villages and health facilities
2. Access to and establishment of trust with our beneficiaries/ customers/ clients/patients
3. Good and reliable insights into pricing and financing of health services/products ,given our presence in the local market scene.
4. Behavior change insights and competencies

Boehringer Ingelheim will contribute:
1.Support for pilot of Action Data Initiative, potentially in a clinical trials setting
2. Understanding of supply chains and how data is used in decision making
3. Global presence and linkages with affiliates and partners
4. Discovering and securing additional partnerships and support based on other BI strategic co-creators

Please describe the potential revenue model for this Co-Creation idea.

Improved data for decision making capabilities has a number of cost saving and revenue generating elements. We envision as a pilot focusing on clinical trail setting, and co-creating other promising action data initiatives that can sustain revenue, then begin to scale up recurring revenue that will finally sustain the whole project. Pharmaceutical companies will pay about$25,000 to accrue a divers group of individuals into clinical study. It is our intention to have competitive rates with value increases in how data is collected and presented . The data provides ready participants that can speed up the recruitment process and at the same time accelerate the study and treatment results.

What possible risks or challenges do you foresee?

The Action Data Initiative will face challenges associated with new digital technology, and the analysis and sharing of data. To mitigate these challenges we can run a mutually beneficial clinical focused pilot to prove that the concept can grow. Other challenges may include changes in project scope and the need for skills training around data management and analysis.

Is there anything else you would like to share about your Co-Creation idea?

We would very much welcome other co-creators' thinking regarding our approach so that together we can co-create a viable product that fits the market well.

How much input do you hope to receive from Boehringer Ingelheim?

I’d like to implement together.

If you selected "other" above, please explain:
Besides Boehringer Ingelheim, what other types of partners might be valuable to carrying out your Co-Creation idea, and why?

A partner with mobile and web technology competencies would be valuable to carrying out our co-Creation idea. This is because of their competencies and skills is designing and developing an efficient, automated data collection process while implementing real time or near-real time analysis and visualization of collected data. The collected data, we believe, will drive insightful meaning on trends and at the same time allow for drill down in these trends.